MedTech & Medical Device M&A: The Exit Delay Opportunity
The Private Equity MedTech Exit Slowdown — and What It Means for New Dealmakers
Higher interest rates have made it harder for private equity funds to exit portfolio companies at the valuations they expected, and the backlog of unsold companies is rippling across the industry, The Wall Street Journal reported. For principals waiting on their “carry checks” that delay is prompting more of them to launch independent searches.
At Kinsella Group, we specialize in the lower end of the MedTech & Medical Device market, where we have deep expertise and a strong track record, with a particular focus on sale mandates in the medtech and med device space.
Our portfolio of successful transactions can be viewed here. Backed by a global network of relationships spanning North America, Europe, and Asia, our team brings the reach and local market knowledge needed to connect buyers and sellers wherever the right opportunity exists.
If we can help, we are happy to join a confidential Zoom or Teams call or meet at one of the upcoming conferences this fall. Please see the list below.
- AAOMS — Sep 30, Seattle
- NASS — Oct 14, San Antonio
- Great Wall Cardiology Meeting — Oct 17, Beijing, China
- MD&M Midwest — Oct 28-29, Minneapolis
- Medica — Nov 16-19, Düsseldorf, Germany
- MEDevice Silicon Valley — Nov 18-19, Santa Clara
- CCJR — Dec 10-11, Orlando
Meet our international MedTech and medical device team here. We look forward to assisting you.
